Elimination of Perinatal Hepatitis B: Providing the First Vaccine Dose Within 24 Hours of Birth.

Published

Journal Article

After the introduction of the hepatitis B vaccine in the United States in 1982, a greater than 90% reduction in new infections was achieved. However, approximately 1000 new cases of perinatal hepatitis B infection are still identified annually in the United States. Prevention of perinatal hepatitis B relies on the proper and timely identification of infants born to mothers who are hepatitis B surface antigen positive and to mothers with unknown status to ensure administration of appropriate postexposure immunoprophylaxis with hepatitis B vaccine and immune globulin. To reduce the incidence of perinatal hepatitis B transmission further, the American Academy of Pediatrics endorses the recommendation of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention that all newborn infants with a birth weight of greater than or equal to 2000 g receive hepatitis B vaccine by 24 hours of age.

Full Text

Duke Authors

Cited Authors

  • COMMITTEE ON INFECTIOUS DISEASES, ; COMMITTEE ON FETUS AND NEWBORN,

Published Date

  • September 2017

Published In

Volume / Issue

  • 140 / 3

PubMed ID

  • 28847980

Pubmed Central ID

  • 28847980

Electronic International Standard Serial Number (EISSN)

  • 1098-4275

Digital Object Identifier (DOI)

  • 10.1542/peds.2017-1870

Language

  • eng

Conference Location

  • United States